Minn.: Alzheimer’s approved for medical cannabis, other conditions rejected

Dec 04, 2018 Alzheimer’s disease, autism, hepatitis C, insomnia, intractable pain, medical cannabis, Medical Marijuana, Minnesota, Minnesota Department of Health, MN, opioid use disorder, PTSD, qualifying conditions, Sensible Minnesota, sleep apnea, traumatic brain injury


Yesterday, the Minnesota Department of Health approved adding Alzheimer’s disease as a qualifying condition for medical cannabis, but rejected opioid use disorder, hepatitis C, traumatic brain injury, and insomnia.

Many thanks to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program! Their dedicated work (with an assist from MPP) also resulted in the addition of intractable pain, PTSD, autism, and sleep apnea.

Under state law, Alzheimer’s disease patients will be able to apply for medical cannabis starting next summer.